Medimetriks (U.S. Development And Commercialization Rights to OPA-15406) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Medimetriks (U.S. Development And Commercialization Rights to OPA-15406) General Information

Description

Development, marketing and manufacturing rights to OPA-15406, a new therapeutic agent in development for atopic dermatitis.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Drug Discovery
Acquirer
Medimetriks Pharmaceuticals
Corporate Office
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medimetriks (U.S. Development And Commercialization Rights to OPA-15406) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Medimetriks (U.S. Development And Commercialization Rights to OPA-15406)‘s full profile, request access.

Request a free trial

Medimetriks (U.S. Development And Commercialization Rights to OPA-15406) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Medimetriks (U.S. Development And Commercialization Rights to OPA-15406)‘s full profile, request access.

Request a free trial

Medimetriks (U.S. Development And Commercialization Rights to OPA-15406) FAQs

  • Where is Medimetriks (U.S. Development And Commercialization Rights to OPA-15406) headquartered?

    Medimetriks (U.S. Development And Commercialization Rights to OPA-15406) is headquartered in .

  • What industry is Medimetriks (U.S. Development And Commercialization Rights to OPA-15406) in?

    Medimetriks (U.S. Development And Commercialization Rights to OPA-15406)’s primary industry is Buildings and Property.

  • Is Medimetriks (U.S. Development And Commercialization Rights to OPA-15406) a private or public company?

    Medimetriks (U.S. Development And Commercialization Rights to OPA-15406) is a Private company.

  • What is the current valuation of Medimetriks (U.S. Development And Commercialization Rights to OPA-15406)?

    The current valuation of Medimetriks (U.S. Development And Commercialization Rights to OPA-15406) is .

  • What is Medimetriks (U.S. Development And Commercialization Rights to OPA-15406)’s current revenue?

    The current revenue for Medimetriks (U.S. Development And Commercialization Rights to OPA-15406) is .

  • Who are Medimetriks (U.S. Development And Commercialization Rights to OPA-15406)’s investors?

    Otsuka (IT Consulting and Outsourcing) has invested in Medimetriks (U.S. Development And Commercialization Rights to OPA-15406).

  • When was Medimetriks (U.S. Development And Commercialization Rights to OPA-15406) acquired?

    Medimetriks (U.S. Development And Commercialization Rights to OPA-15406) was acquired on 08-Feb-2016.

  • Who acquired Medimetriks (U.S. Development And Commercialization Rights to OPA-15406)?

    Medimetriks (U.S. Development And Commercialization Rights to OPA-15406) was acquired by Medimetriks Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process